Charles Schwab Discloses Results of the Federal Reserve's 2025 Comprehensive Capital Analysis and Review
This 2.5% SCB will continue to be applicable to Schwab for the four-quarter period beginning October 1, 2025. Schwab's Common Equity Tier 1 (CET1) ratio of 32% as of March 31, 2025 was well in excess of the regulatory minimum of 4.5% combined with the SCB of 2.5% due to the relatively low risk nature of our balance sheet assets.
Schwab ended the first quarter of 2025 with a consolidated adjusted Tier 1 Leverage Ratio of 7.13%, up from 6.85% at year-end 2024. This consolidated adjusted Tier 1 Leverage Ratio is above the long-term operating objective for CSC of 6.75% to 7.00%.
CFO Mike Verdeschi commented, 'Schwab's CCAR stress test results reinforce the strength of our capital position and durability of our diversified model across a range of environments. The firm will continue to prioritize maintaining capital levels to support the evolving needs of our clients as well as long-term franchise growth – while at the same time seeking to enhance through-the-cycle stockholder value via the opportunistic return of capital in multiple forms.'
Forward-looking Statements
This press release contains forward-looking statements relating to the company's business results, capital ratios, balance sheet management and capital return. These forward-looking statements reflect management's expectations as of the date hereof. Achievement of these expectations and objectives is subject to risks and uncertainties that could cause actual results to differ materially from the expressed expectations. Important factors that may cause such differences are described in the company's most recent reports on Form 10-K and Form 10-Q, which have been filed with the Securities and Exchange Commission and are available on the company's website (https://www.aboutschwab.com/financial-reports) and on the Securities and Exchange Commission's website (https://www.sec.gov). The company makes no commitment to update any forward-looking statements.
About Charles Schwab
The Charles Schwab Corporation (NYSE: SCHW) is a leading provider of financial services, with 37.4 million active brokerage accounts, 5.6 million workplace plan participant accounts, 2.1 million banking accounts, and $10.35 trillion in client assets as of May 31, 2025. Through its operating subsidiaries, the company provides a full range of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services to individual investors and independent investment advisors. Its broker-dealer subsidiary, Charles Schwab & Co., Inc. (member SIPC, https://www.sipc.org), and its affiliates offer a complete range of investment services and products including an extensive selection of mutual funds; financial planning and investment advice; retirement plan and equity compensation plan services; referrals to independent, fee-based investment advisors; and custodial, operational and trading support for independent, fee-based investment advisors through Schwab Advisor Services. Its primary banking subsidiary, Charles Schwab Bank, SSB (member FDIC and an Equal Housing Lender), provides banking and lending services and products. More information is available at https://www.aboutschwab.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
2 Dividend ETFs to Buy With $500 and Hold Forever
Dividend investors generally fall into two broad categories, seeking either dividend growth or high yield. The Vanguard Dividend Appreciation ETF will appeal to dividend growth investors. The Schwab U.S. Dividend Equity ETF is for those seeking a high yield. 10 stocks we like better than Vanguard Dividend Appreciation ETF › If you have $500 to invest and love dividends, you have plenty of stocks to choose from. But $500 won't necessarily get you a diversified portfolio of individual stocks. For that sum, you may be better off buying an exchange-traded fund (ETF) that prioritizes dividend income. Two of the best options for buy-and-hold investors today are the Vanguard Dividend Appreciation ETF (NYSEMKT: VIG) and the Schwab U.S. Dividend Equity ETF (NYSEMKT: SCHD). Each one appeals to a different kind of income investor. Most dividend investors look first at a stock's yield, but another important factor is the growth potential of the dividend over time. This is exactly the focus of the Vanguard Dividend Appreciation ETF. While the ETF's yield is only around 1.8% as of this writing, the quarterly dividend has nearly doubled over the past decade, and that payout growth has been accompanied by a roughly 170% increase in the share price of the ETF. To achieve this result, the ETF follows the S&P U.S. Dividend Growers index, which looks at all U.S. companies that have increased their dividends for a decade or longer. The index then removes the highest yielding 25% of the list. What's left is included in the index -- and the ETF -- weighted by market cap. The expense ratio is a very low 0.05%. While the yield today may not excite you, that's not what the Vanguard Dividend Appreciation ETF is trying to do. It is attempting to provide you with growth of capital and income. With $500, you can buy two shares of the ETF, which will start you along an investment journey that can lead to a very attractive retirement portfolio years from now. If you don't have that much time before you retire and would like to generate a little more income in the here and now, then the Schwab U.S. Dividend Equity ETF might be a better choice. It is offering a nearly 4% yield as of this writing and also comes with a modest expense ratio of 0.06%. But the big question is: What backs the yield? The Schwab U.S. Dividend Equity ETF tracks the Dow Jones U.S. Dividend 100 index. Its construction is a lot more complex than the index backing the Vanguard ETF. But in essence, the Dow Jones U.S. Dividend 100 index follows some of the core criteria you would likely follow if shopping for individual stocks. Specifically, the index screens for companies that have increased their dividends for a decade or more (excluding real estate investment trusts). A composite score is created for the qualifying companies that looks at the ratio of cash flow to total debt, return on equity, dividend yield, and the company's five-year dividend growth rate. The 100 companies with the highest composite scores are included in the index and the ETF (again weighted by market cap). The outcome of this has been a rising dividend, rising share price, and a generous yield. In fact, the dividend here has grown more quickly than that of the Vanguard Dividend Appreciation ETF over the past decade, but the price gain has been smaller. A $500 investment will get you around 18 shares of the Schwab U.S. Dividend Equity ETF. A lot of exchange-traded funds throw the word "dividend" into their names, but they are not all created equal. If you have more time on your side, the Vanguard Dividend Appreciation ETF is the kind of investment with which you can build long-term wealth. If you are more focused on generating income right now, you may prefer the Schwab U.S. Dividend Equity ETF. That said, both of these dividend ETFs stand out from the pack as buy-and-hold choices for those whose investment time frame is "forever." Before you buy stock in Vanguard Dividend Appreciation ETF, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Vanguard Dividend Appreciation ETF wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $699,558!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $976,677!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 30, 2025 Reuben Gregg Brewer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Vanguard Dividend Appreciation ETF. The Motley Fool has a disclosure policy. 2 Dividend ETFs to Buy With $500 and Hold Forever was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Yahoo
Surmodics still recovering after June cyberattack
Surmodics has revealed that it is still recovering after it was hit by a cyberattack in June 2025. In a Form 8-K filed with the US Securities and Exchange Commission (SEC), the maker of the Pounce XL thrombectomy system for clot removal said that on 5 June, the US-based company discovered that a third party had gained unauthorised access to 'certain' IT systems, rendering them 'unavailable' to the company. Surmodics has been able to continue accepting customer orders and shipping products without any customer impact by using alternative IT systems following the breach. The company noted that to its knowledge, the threat actor had not released any of its data, including any third-party data, or used any such data for any fraudulent purposes. It continues to evaluate the 'scope and details of the IT data' stolen in the attack. Containment measures were initiated once the breach was identified, with certain IT systems taken offline. Surmodics added that it implemented its security incident response plan and that remaining IT systems and data are currently being restored and validated. Surmodics is not the only medtech company to have experienced a cyberattack this year. In May, medical technology company Masimo revealed that 'unauthorised activity' had been detected on its on-premise network in April. The incident disrupted certain activities at the patient monitoring company's manufacturing facilities and hindered its ability to process and ship customer orders effectively. According to Masimo, the attack did not affect its cloud-based hospital data systems, with no evidence of any employee or patient data being compromised. Research indicates that cyberattacks on healthcare organisations are on the rise, due in part to outdated legacy systems and increased vulnerabilities due to the rise of Internet of Things (IoT) devices and the overall richness of the data available to bad actors. According to KPMG, due to cyber threats, the functioning of healthcare systems has reached a 'tipping point'. With the rise of AI-powered medical transcription tools being deployed in healthcare systems, KPMG states that there is an increasing onus on chief information security officers (CISOs) to ensure that data privacy, access management, and other security protocols are well-developed as a means to protect sensitive patient information. According to GlobalData, cybersecurity spending by healthcare providers is growing at a CAGR of 12.5% to reach a valuation of $10.9bn by 2027. "Surmodics still recovering after June cyberattack" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
CNBC
3 days ago
- CNBC
CNBC Daily Open: U.S. markets say 'yes' to cheaper shoes from Vietnam, 'eh' to job losses
If I had to choose between having a job and paying less for Nike shoes, you'd see me running barefoot to the office. Wednesday's market moves, however, suggested that Wall Street preferred the cheaper shoes. The U.S. economy lost private sector jobs in June, the first time hiring had contracted since March 2023, according to payrolls processing firm ADP. It's even more startling because a Dow Jones survey of economists had pegged job numbers to expand by 100,000. Meanwhile, U.S. President Donald Trump announced on his social media site Truth Social that the country had made a trade deal with Vietnam, in which the Southeast Asian nation will face a 20% duty on imports to America. That means companies that rely heavily on Vietnam for manufacturing, such as Nike, Crocs and Lululemon, will face less onerous costs and might not hike prices as much, compared with the original tariff rate of 46%. After weighing both pieces of news, investors decided the good news was more important and lifted the S&P 500 to a new closing high. Granted, the ADP report has had a spotty track record in predicting the official job figures from the U.S. Bureau of Labor Statistics. But it's still worth thinking about how that's a sign financial markets could be slightly disconnected from the real economy: Who can afford to buy shoes and pump up stocks if they don't have jobs? Vietnam strikes a deal with America. Imports from the Southeast Asian nation to the U.S. will be subject to a 20% tariff, while the U.S. gets tariff-free access to Vietnam's market, Trump announced Wednesday. The S&P 500 rises to close at a fresh record. On Tuesday, the index also scored an intra-day high, while the Nasdaq Composite notched a record close. The Vietnam Index on Wednesday rose to its highest level since April 2022, following news of the country's deal with America. The White House lifts chip software curbs on China. Semiconductor software companies Synopsys and Cadence announced Thursday that they are restoring access to their products after the U.S. government reversed export restrictions. U.S. private sector jobs shrank in June. Job losses amounted to 33,000, reported ADP on Wednesday. Economists polled by Dow Jones had expected an increase of 100,000 jobs for the month. [PRO] Revenue-generating concerts are boosting K-pop stocks. Amid declining sales of music albums, K-pop agencies are pivoting their strategy — leading to a surge of over 100% in stock price for some. Hong Kong's IPO market is on fire — here's what's fueling the surge New listing volumes on the Hong Kong Stock Exchange jumped around eight times to $14 billion in the first half of this year, from just $1.8 billion in the same period in 2024, according to Dealogic. That puts the city on track to become the world's largest listing destination this year, surpassing the Nasdaq and the New York Stock Exchange. PwC projected up to 100 IPOs in Hong Kong this year, with total fundraising to exceed $25.5 billion.
